Abstract:Background: Genetic factors account for approximately 35% of colorectal cancer risk. The specificity and sensitivity of previous diagnostic biomarkers for colorectal cancer could not meet the need of clinical application. The expanding scale and inherent complexity of biological data have encouraged a growing use of machine learning to build informative and predictive models of the underlying biological processes. The aim of this study is to identify diagnostic genes of colorectal cancer by using machine learning methods. Methods: The GSE41328 and GSE106582 data sets were downloaded from the Gene Expression Omnibus (GEO) database. The gene expression differences between colon cancer and normal tissues were analyzed. The key colorectal cancer genes were screened and validated by Least Absolute Shrinkage and Selection Operator (LASSO) and Support Vector Machine (SVM) regression. Immune cell infiltration and the correlation with the key genes in patients with colon cancer were further analyzed by CIBERSORT. Results: Eleven key genes were identified as biomarkers for colon cancer, namely ASCL2, BEST4, CFD, DPEPCFD, FOXQ1, TRIB3, KLF4, MMP7, MMP11, PYY, and PDK4. The mean area under the receiver operating characteristic (ROC) curve (AUC) of all 11 genes for colon cancer diagnosis were 0.94 with a range of 0.91-0.97. In the validation set, the expression of the 11 key genes was significantly different between colon cancer and normal subjects (P<0.05) and the mean AUCs were 0.82 with a range of 0.70-0.88. Immune cell infiltration analyses demonstrated that the relative quantity of plasma cells, T cells, B cells, NK cells, MO, M1, Dendritic cells resting, Mast cells resting, Mast cells activated, and Neutrophils in the tumor group were significantly different to the normal group. Conclusions: ASCL2, BEST4, CFD, DPEPCFD, FOXQ1, TRIB3, KLF4, MMP7, MMP11, PYY, and PDK4 were identified as the key genes for colon cancer diagnosis. These genes are expected to become novel diagnostic markers and targets of new pharmacotherapies for colorectal cancer.

A brief survey of machine learning application in cancerlectin identification.

Identification of Lactylation Gene CALML5 and Its Correlated Lncrnas in Cutaneous Melanoma by Machine Learning.

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Lectin: A Molecular Tool in Cancer Diagnosis and Therapy with Special Reference to Reproductive Cancers

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles

Lectins as versatile tools to explore cellular glycosylation

Identidication of novel biomarkers in non-small cell lung cancer using machine learning

Lectin-glycan interactions: a comprehensive cataloguing of cancer-associated glycans for biorecognition and bio-alteration: a review

Identification of Colon Immune Cell Marker Genes Using Machine Learning Methods.

Lectin microarrays: a powerful tool for glycan-based biomarker discovery.

Rapid and precise detection of cancers via label-free SERS and deep learning

Lectin-Based Approaches to Analyze the Role of Glycans and Their Clinical Application in Disease

Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis

Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification

Identification of N-glycan moiety of tumor marker by lectin microarray

Fingerprint Profiling of Glycans on Extracellular Vesicles via Lectin-Induced Aggregation Strategy for Precise Cancer Diagnostics

A Machine Learning-Based Investigation of Integrin Expression Patterns in Cancer and Metastasis

LectoScape: A Highly Multiplexed Imaging Platform for Glycome Analysis and Biomedical Diagnosis.

The multiple roles of C-type lectin receptors in cancer

Diagnosis of hepatocellular carcinoma based on salivary protein glycopatterns and machine learning algorithms

Identifying the Signatures and Rules of Circulating Extracellular MicroRNA for Distinguishing Cancer Subtypes